Skip to content

US · GRDX · BIOTECHNOLOGY

GridAI Technologies Corp. (GRDX) intrinsic value and stock valuation

$3.16as of 2026-11-21 · Mkt cap 9.31M

Data updated · price as of 2026-11-21

IC valuationIntrinsic value, upside vs price and the fair-value band are available to Pro members.
P/E
Pro
P/B
Pro
P/S
Pro

Price history

Price charts, the InvestorsCraft value line, and the fair-value band are Pro features.

GridAI Technologies Corp. DCF and intrinsic value

InvestorsCraft values GRDX with the Chepakovich two-stage DCF model. How the model works · Run your own DCF prefilled from GRDX’s statements →

GridAI Technologies Corp. Graham Number

The Graham Number is not defined for negative earnings or book value. Guide · Calculator →

Healthcare · Biotechnology Boca Raton, FL 33431 grid-ai.com

How the business is doing

Fiscal 2013–2025, USD

Revenue
$40K
20132025
Net income
-$-6.39M
20132025
Free cash flow
-$-5.7M
20132025
Total equity
$28.8M
20132025

Is it expensive?

Each multiple against its own 15-year range, or against peers where no history is available

P/E
Pro
with Pro
P/B
Pro
with Pro
P/S
Pro
with Pro
EV/EBITDA
Pro
with Pro
P/EG
Pro
with Pro
P/TBV
Pro
with Pro

Peers

Same-industry companies, ranked by market cap

Peer comparison

The peer comparison table is shown only to users with a Pro subscription.

Financials

Statements by fiscal year

Fiscal 2013–2025, USD
20252024202320222021
Revenue$40K$0.00$0.00$0.00$0.00
Operating income-$-7.08M-$-15.62M-$-15.77M-$-12.68M-$-59.06M
Net income-$-6.39M-$-18.06M-$-15.79M-$-14.63M-$-58.54M
EPSd-$-3.94M-$-5.27M-$-46.44M-$-365.75M—
Operating cash flow-$-5.7M-$-9.22M-$-12.38M-$-22.34M-$-32.29M
Capital expenditure$0.00$0.00-$-500K$0.00-$-10.32M
Free cash flow-$-5.7M-$-9.22M-$-12.88M-$-22.34M-$-42.61M
Total assets$48.6M$85.4M$6.88M$5.44M$11.8M
Total debt$2.26M$140K$830K$880K$1.03M
Net debt$1.36M-$-20K-$-2.88M-$-480K-$-7.22M
Total equity$28.8M$57.8M$3.6M$2.74M-$-7.82M
Cash and short-term investments$900K$160K$3.71M$1.36M$8.25M
Income statement
20252024202320222021
Revenue$40K$0.00$0.00$0.00$0.00
Cost of revenue$1.27M$50K$30K$110K$540K
Gross profit-$-1.23M-$-50K-$-30K-$-110K-$-540K
Research and development expenses$930K$0.00$5.03M$690K$38.3M
Selling, general and administrative expenses$5.5M$14.7M$10.7M$12M$18.4M
Other expenses-$-570K$900K$0.00$0.00$2.35M
Operating expenses$5.85M$15.6M$15.8M$12.7M$59.1M
Cost and expenses$7.12M$15.6M$15.8M$12.7M$59.1M
Interest income$0.00$0.00$0.00$10K$0.00
Interest expense$490K$0.00$20K$20K$10K
Depreciation and amortization$570K$50K$30K$30K$540K
Ebitda-$-6.51M-$-15.57M-$-15.74M-$-14.58M-$-57.99M
Operating income-$-7.08M-$-15.62M-$-15.77M-$-12.68M-$-59.06M
Total other income/expenses, net$440K$0.00-$-20K-$-1.95M$520K
Income before tax-$-6.64M-$-15.62M-$-15.79M-$-14.63M-$-58.54M
Income tax expense-$-400K$0.00$0.00$0.00$0.00
Net income-$-6.39M-$-18.06M-$-15.79M-$-14.63M-$-58.54M
Weighted average shares outstanding$1.62M$4.65M$340K$40K$0.00
Weighted average diluted shares outstanding$1.62M$3.43M$340K$40K$0.00
Balance sheet
20252024202320222021
Cash and short-term investments$900K$160K$3.71M$1.36M$8.25M
Net receivables$1.34M$0.00$0.00$90K$0.00
Inventory$0.00$0.00$0.00$1.95M$0.00
Total current assets$2.6M$83.5M$4.96M$3.41M$9.42M
Property, plant and equipment, net$0.00$130K$210K$300K$410K
Goodwill and intangible assets$46M$1.68M$1.68M$1.68M$1.91M
Long-term investments$0.00$20K$20K$20K$0.00
Total non-current assets$46M$1.93M$1.93M$2.03M$2.37M
Total assets$48.6M$85.4M$6.88M$5.44M$11.8M
Accounts payable$3.38M$2.96M$550K$720K$2.71M
Short-term debt$2.26M$160K$680K$670K$720K
Deferred revenue$0.00$0.00$0.00$0.00$0.00
Total current liabilities$15.2M$27.6M$3.13M$2.48M$12.3M
Long-term debt$0.00$60K$150K$210K$310K
Deferred revenue, non-current$0.00$0.00$0.00$0.00$0.00
Total non-current liabilities$4.56M$60K$150K$210K$7.31M
Capital lease obligations$240K$140K$210K$280K$390K
Total liabilities$19.7M$27.6M$3.28M$2.7M$19.6M
Common stock$0.00$0.00$0.00$0.00$0.00
Retained earnings-$-208.78M-$-202.39M-$-184.33M-$-168.53M-$-153.9M
Accumulated other comprehensive income (loss)$40K$0.00$0.00$0.00-$-1.22M
Total equity$28.8M$57.8M$3.6M$2.74M-$-7.82M
Total investments$0.00$20K$20K$20K$0.00
Total debt$2.26M$140K$830K$880K$1.03M
Net debt$1.36M-$-20K-$-2.88M-$-480K-$-7.22M
Cash flow statement
20252024202320222021
Net income-$-6.55M-$-18.06M-$-15.79M-$-14.63M-$-58.54M
Depreciation and amortization$570K$50K$30K$30K$540K
Stock-based compensation$730K$630K$1.04M$770K$1.37M
Change in working capital-$-340K$2.53M$2.19M-$-10.5M$17.1M
Accounts receivable-$-1.62M$0.00$90K-$-90K$550K
Inventory$0.00$0.00$0.00$0.00$0.00
Accounts payable$470K$1.64M-$-170K-$-1.99M$1.42M
Net cash provided by operating activities-$-5.7M-$-9.22M-$-12.38M-$-22.34M-$-32.29M
Investments in property, plant and equipment$0.00$0.00-$-500K$0.00-$-10.32M
Acquisitions, net$320K$90K$0.00$0.00$0.00
Net cash used for investing activities$320K$90K-$-500K$0.00-$-10.32M
Common stock issued$3.64M$6.23M$15.8M$23.1M$32.7M
Common stock repurchased$0.00$0.00$0.00$0.00$0.00
Dividends paid$0.00-$-240K$0.00$0.00$0.00
Net cash used for financing activities$5.89M$5.58M$15.2M$15.7M$44.8M
Net change in cash$710K-$-3.55M$2.35M-$-6.86M$2.19M
Cash at end of period$900K$180K$3.73M$1.38M$8.25M
Operating cash flow-$-5.7M-$-9.22M-$-12.38M-$-22.34M-$-32.29M
Capital expenditure$0.00$0.00-$-500K$0.00-$-10.32M
Free cash flow-$-5.7M-$-9.22M-$-12.88M-$-22.34M-$-42.61M
USD millions

Line items

    USD millions

    Line items

      USD millions

      Line items

        About GridAI Technologies Corp.

        GridAI Technologies Corp. functions as a clinical-stage biopharmaceutical enterprise primarily dedicated to developing precise, locally-acting treatments for various digestive system ailments. Its core activity involves researching and advancing therapeutic solutions specifically designed for patients with gastrointestinal diseases. The company's pipeline features several key drug candidates, including Latiglutenase, Capeserod, Adrulipase, and Niclosamide. GridAI Technologies was established on January 30, 2014, and maintains its principal offices in Boca Raton, Florida.

        CEO
        Jason David Sawyer
        Employees
        2
        Beta
        1.87

        Explore

        Frequently asked questions

        What is the intrinsic value of GridAI Technologies Corp. (GRDX)?

        InvestorsCraft does not currently publish an intrinsic value for GRDX. How the IC value is calculated.

        Is GRDX undervalued?

        InvestorsCraft does not publish an undervaluation signal for GRDX at this time.

        How is the intrinsic value calculated?

        InvestorsCraft estimates intrinsic value with four methods: the Chepakovich valuation model (IC), an AI-assisted estimate, the Graham-Dodd formula, and the Graham Formula. How the IC value is calculated.

        How often is this page updated?

        Prices are refreshed each trading day; valuation inputs update when new financial statements are processed. This page was last updated Nov 21, 2026.

        Disclaimer: Information on this page is provided for educational purposes only and does not constitute investment advice. Figures marked d are derived from the figures shown — for example upside = IC ÷ price − 1, CAGR over the last five fiscal years, and range bounds are 15-year or peer minimum and maximum.